NCT02199665
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02199665
Title Selinexor, Carfilzomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma (SINE)
Acronym SINE
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors University of Chicago
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Mayo Clinic (AZ) Scottsdale Arizona 85259 United States Details
University of Chicago Chicago Illinois 60637 United States Details
University of Michigan Comprehensive Cancer Center Ann Arbor Michigan 48109 United States Details
Wayne State University Karmanos Cancer Institute Detroit Michigan 48201 United States Details
Mount Sinai Medical Center New York New York 10029 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field